This drug, the first of its chemical type, will be available as capsules to treat chronic idiopathic constipation, defined as infrequent or difficult passage of stool.

Advertisement

The condition affects women more often than men and is more common in people older than 65. Symptoms include abdominal pain and discomfort, bloating, straining, and hard stools.

Amitiza increases intestinal fluid secretion, which helps ease passage of stool and alleviate symptoms associated with chronic idiopathic constipation, the FDA said.

The agency's approval is based on two clinical trials of the drug that concluded that taking the drug was associated with higher frequency of bowel movements. Side effects included headache, nausea, diarrhoea, abdominal pain, and distension.

The drug is taken twice a day with food, the FDA said. – (HealthDayNews)

Read more: Constipation

February 2006
 

Print this article on

Rate this article Poor 1 2 3 4 5 Excellent

JOBS

DELPHI DEVELOPER Gauteng - Johannesburg C++ DEVELOPERS Gauteng SENIOR C++ DEVELOPERS Gauteng - Johannesburg SENIOR .NET DEVELOPERS Gauteng SNR C# / .NET DEVELOPER Gauteng WEB DEVELOPERS Gauteng JAVA / J2EE DEVELOPERS Gauteng C# DEVELOPERS Gauteng - Pretoria Find more jobs Register your CV Post a job